119 related articles for article (PubMed ID: 20859709)
21. Arsenic disulfide promoted the demethylation of
Chen C; Wang L; Liu Y; Du S; Teng Q
PeerJ; 2024; 12():e17363. PubMed ID: 38766487
[TBL] [Abstract][Full Text] [Related]
22. Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma.
Zainuddin N; Kanduri M; Berglund M; Lindell M; Amini RM; Roos G; Sundström C; Enblad G; Rosenquist R
Leuk Res; 2011 Apr; 35(4):438-43. PubMed ID: 21035853
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
Tam W; Gomez M; Chadburn A; Lee JW; Chan WC; Knowles DM
Blood; 2006 May; 107(10):4090-100. PubMed ID: 16424392
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
Ferraresso S; Bresolin S; Aricò A; Comazzi S; Gelain ME; Riondato F; Bargelloni L; Marconato L; Kronnie Gt; Aresu L
PLoS One; 2014; 9(4):e92707. PubMed ID: 24695110
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma.
Huang W; Xue X; Shan L; Qiu T; Guo L; Ying J; Lu N
BMC Cancer; 2017 Dec; 17(1):815. PubMed ID: 29202805
[TBL] [Abstract][Full Text] [Related]
26. Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
Wang XM; Greiner TC; Bibikova M; Pike BL; Siegmund KD; Sinha UK; Müschen M; Jaeger EB; Weisenburger DD; Chan WC; Shibata D; Fan JB; Hacia JG
J Cell Biochem; 2010 Mar; 109(4):818-27. PubMed ID: 20069569
[TBL] [Abstract][Full Text] [Related]
27. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
Rinaldi A; Mensah AA; Kwee I; Forconi F; Orlandi EM; Lucioni M; Gattei V; Marasca R; Berger F; Cogliatti S; Cavalli F; Zucca E; Gaidano G; Rossi D; Bertoni F
Br J Haematol; 2013 Oct; 163(2):194-204. PubMed ID: 23961875
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.
Pike BL; Greiner TC; Wang X; Weisenburger DD; Hsu YH; Renaud G; Wolfsberg TG; Kim M; Weisenberger DJ; Siegmund KD; Ye W; Groshen S; Mehrian-Shai R; Delabie J; Chan WC; Laird PW; Hacia JG
Leukemia; 2008 May; 22(5):1035-43. PubMed ID: 18288132
[TBL] [Abstract][Full Text] [Related]
32. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
33. Distinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma.
Lock FE; Rebollo R; Miceli-Royer K; Gagnier L; Kuah S; Babaian A; Sistiaga-Poveda M; Lai CB; Nemirovsky O; Serrano I; Steidl C; Karimi MM; Mager DL
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):E3534-43. PubMed ID: 25114248
[TBL] [Abstract][Full Text] [Related]
34. Possible Role of GADD45γ Methylation in Diffuse Large B-Cell Lymphoma: Does It Affect the Progression and Tissue Involvement?
Barış İC; Caner V; Şen Türk N; Sarı İ; Hacıoğlu S; Doğu MH; Çetin O; Tepeli E; Can Ö; Bağcı G; Keskin A
Turk J Haematol; 2015 Dec; 32(4):295-303. PubMed ID: 25912017
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.
Ferraresso S; Aricò A; Sanavia T; Da Ros S; Milan M; Cascione L; Comazzi S; Martini V; Giantin M; Di Camillo B; Mazzariol S; Giannuzzi D; Marconato L; Aresu L
Sci Rep; 2017 Sep; 7(1):11591. PubMed ID: 28912427
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN
Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061
[TBL] [Abstract][Full Text] [Related]
37. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
38. AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines.
Jiao J; Lv Z; Zhang P; Wang Y; Yuan M; Yu X; Otieno Odhiambo W; Zheng M; Zhang H; Ma Y; Ji Y
Neoplasia; 2020 Mar; 22(3):142-153. PubMed ID: 32062068
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
40. Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell Lymphoma.
Mohamed G; Talima S; Li L; Wei W; Rudzki Z; Allam RM; Simmons W; Tao Q; Murray PG
Pathol Oncol Res; 2019 Jul; 25(3):1223-1231. PubMed ID: 30739251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
